Intersect ENT, Inc
XENT
XENT was delisted on the 12th of May, 2022.
108 hedge funds and large institutions have $611M invested in Intersect ENT, Inc in 2021 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 35 increasing their positions, 39 reducing their positions, and 15 closing their positions.
4% more call options, than puts
Call options by funds: $6.7M | Put options by funds: $6.43M
2% less funds holding
Funds holding: 110 → 108 (-2)
8% less capital invested
Capital invested by funds: $661M → $611M (-$49.7M)
10% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 39
13% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 15
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$18.8M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$18.5M |
| 3 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$8.77M |
| 4 |
SAM
Silvercrest Asset Management
New York
|
+$7.19M |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$21.7M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$6.29M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.65M |
| 4 |
PFM
Premier Fund Managers
Guildford,
United Kingdom
|
-$3.32M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$3.26M |
XENT Hedge Fund Activity: Q1 2021 in Review
108 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q1 2021, worth a combined $611M — down 7.5% from $661M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of XENT and 13 opened new positions — a net loss of 2 holders — while 39 trimmed existing stakes and 35 added.
The largest buyer was First Light Asset Management, adding an estimated $18.8M. The largest seller was UBS Group, cutting an estimated $21.7M.
- 108 institutional investors held Intersect ENT, Inc (XENT) as of Q1 2021, down from 110 in Q4 2020.
- Funds reported $611M of Intersect ENT, Inc stock for Q1 2021, down 7.5% quarter-over-quarter.
- 13 funds opened new Intersect ENT, Inc positions in Q1 2021 and 15 closed out, a net change of -2 holders.
- The largest Intersect ENT, Inc buyer in Q1 2021 was First Light Asset Management, an estimated $18.8M added.
- The largest Intersect ENT, Inc seller in Q1 2021 was UBS Group, an estimated $21.7M sold.
Based on aggregated 13F filings for Q1 2021.